Microplastics are small plastic particles, typically defined as <5 mm in size, that have become widespread in air, water, and foods. Public health concern has increased because microplastics can enter the human body through multiple routes, including ingestion, inhalation, and possibly dermal exposure. A frequently discussed pathway is oral exposure: everyday behaviors such as eating or chewing may increase contact between particles and the gastrointestinal tract. The key medical question is not only whether microplastics are detectable in the body, but how they might contribute to inflammation, metabolic dysregulation, gut dysfunction, and neurocognitive symptoms. After exposure, microplastics can interact with the lining of the oral cavity and the digestive tract. Particles may adsorb dietary components and environmental chemicals, creating a complex exposure mixture. In the mouth and gastrointestinal tract, microplastics can physically irritate tissues and may also trigger innate immune responses. Mechanistically, one proposed pathway involves activation of pattern recognition receptors and downstream signaling (e.g., NF-κB and inflammasome pathways), promoting pro-inflammatory cytokine release. This inflammatory cascade can affect local tissues and may also influence systemic inflammation through translocation of mediators or effects on the gut barrier. A second major concern is the role of the gut barrier and the intestinal microbiome. The intestinal epithelium normally limits translocation of pathogens and toxins. If microplastics or co-adsorbed chemicals impair epithelial integrity, they can increase permeability (often termed “leaky gut” in popular language), facilitating endotoxin and inflammatory signal exposure to immune cells. Parallel to barrier dysfunction, the microbiome may be altered by particulate stressors, changes in bile acid metabolism, and altered nutrient absorption. Dysbiosis can further perpetuate inflammation via short-chain fatty acid reductions, impaired mucosal immune regulation, and increased oxidative stress. Microplastics may also act as carriers for chemical additives and contaminants. Plastics contain or release various additives such as plasticizers, stabilizers, and flame retardants. These substances can leach from particles in vivo depending on pH, residence time, and particle chemistry. Many additives have biologically plausible effects on endocrine signaling, oxidative balance, and immune regulation. Importantly, the risk profile is likely heterogeneous: particle size, polymer type, surface charge, and chemical payload determine bioactivity. Therefore, exposure dose and particle characteristics are central to understanding health effects. Systemic consequences reported or hypothesized include inflammation-driven metabolic changes and gastrointestinal symptoms. Inflammation can influence appetite regulation, insulin sensitivity, and vascular function. In the gut, inflammation may contribute to dyspepsia, altered stool patterns, and discomfort via visceral hypersensitivity and immune-mediated effects. However, translation from mechanistic plausibility to clinically established outcomes remains an evolving area. Human epidemiologic evidence is still developing, and direct causal links between a specific behavior (such as chewing gum) and specific diseases are not yet definitive in the current literature. Still, the detection of microplastics in biological specimens and the consistency of pro-inflammatory mechanisms in experimental studies support ongoing risk evaluation. Neurocognitive effects such as “brain fog” are also under investigation. The brain can be influenced indirectly through systemic inflammation, oxidative stress, and vascular signaling, even without direct particle translocation to neural tissue. The gut–brain axis provides a biological bridge: inflammatory cytokines and microbial metabolites can affect neurotransmitter systems, neurovascular coupling, and microglial activation. Additionally, endocrine and oxidative pathways driven by chemical additives could plausibly affect cognitive function, attention, and fatigue. The medical literature, however, emphasizes caution: association does not prove causation, and confounding factors (diet quality, stress, baseline inflammation, occupational exposures) are common in real-world settings. From a practical prevention standpoint, the most evidence-aligned approach is reduction of overall microplastic exposure rather than focusing on a single product. Strategies include choosing foods with lower risk of contamination (e.g., avoiding repeated heating in plastic containers), reducing reliance on single-use plastics, favoring filtration for drinking water where appropriate, and minimizing exposure to dust and airborne particulates. In clinical contexts, when patients report persistent gastrointestinal or cognitive symptoms, clinicians should consider comprehensive differential diagnosis (dietary triggers, inflammatory bowel disease, celiac disease, medication effects, sleep disorders, anxiety/depression, and neurodegenerative etiologies) rather than attributing symptoms solely to microplastics. In summary, microplastics are biologically active exposures that may contribute to inflammation and gut–brain signaling via immune activation, gut barrier disruption, microbiome alteration, and chemical additive effects. While specific behaviors and particle doses are still being clarified, the broader medical consensus supports minimizing exposure and continuing high-quality human research to define causal relationships and quantify risk. Source: [@ABridgen / Jun 4, 2026]
Andrew Bridgen: Studies show chewing a single piece of gum can release up to 3,000 microplastic particles into your mouth in just 8 minutes of chewing. 30,000+ microplastics a year Straight into your saliva and bloodstream Inflammation, gut issues, brain fog all wrapped in bubblegum flavour. #breaking
— @ABridgen May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
